CSIMarket


Medifast Inc   (MED)
Other Ticker:  
 


 

Medifast Inc

MED's Financial Statements and Analysis



Medifast Inc reported in the forth quarter of 2023 net earnings per share of $0.55 a decrease by -77.21 % year on year from $2.43 and decline of -73.86 % from $2.12 earned in III. Quarter (Sep 30 2023).


forth quarter of 2023
Earnings Per Share Revenues
$ 0.55 $  192 Mill
$-1.88     -77.21 % $-145M     -43.13 %



Medifast Inc 's Revenue fell by -43.13 % in forth quarter of 2023 (Dec 31 2023) year on year, to $192 million and declined by -18.52 % sequentially.


Medifast Inc is

More on MED's Income Statement



Medifast Inc 's net income of $6.036 million in the forth quarter of 2023 decreased by -77.24 % from net earnings of $26.519 million achieved in IV. Quarter a year ago.

Sequentially net earnings fell by -73.91 % from net income of $23.131 million realized in previous quarter.

More on MED's Growth

Medifast Inc Inventories
Inventories declined by -54.07 % to $54.59 million from IV. Quarter a year ago, sequentially inventories fell by -6.24 %. In Dec 31 2023 company's net cash and cash equivalents decreased by $-18 million, capital expenditures grew by -9.064-89.56%, to $-1 millions compare to same quarter a year ago

More on MED's Cash flow Statement


Medifast Inc payed out dividend of $4.95 per share in last 52 weeks representing 54.34 % of net earning per share in trailing twelve-month period.

During the same period Medifast Inc earned $ 13.52 cash per share, on a free-cash flow basis 148.36 % of net earning per share.

Book value grew by 4.45 % sequentially to $18.44 per share, 51.51% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 18.44 per share from $ 17.66.

Company repurchased 0.01 million shares or 0.08 % in Dec 31 2023.
Interest Coverage Ratio was 52.73.

More on MED's Dividends

 Market Capitalization (Millions) 400
 Shares Outstanding (Millions) 11
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,072
 Net Income (TTM) (Millions $) 99
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) -6
 Dividend TTM ($) 4.95 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 425




Medifast Inc payed out dividend of $4.95 per share in the last 52 weeks representing 54.34 % of net earning per share in trailing twelve-month period.

During the same period Medifast Inc had $ 13.52 cash flow per share, on a free-cash flow basis 148.36 % of net earning per share.

Book value grew by 4.45 % sequentially to $18.44 per share, 51.51% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 18.44 per share from $ 17.66.

Company repurchased 0.01 million shares or 0.08 % in Dec 31 2023.
Interest Coverage Ratio was 52.73.

More on MED's Balance Sheets

 Market Capitalization (Millions) 400
 Shares Outstanding (Millions) 11
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,072
 Net Income (TTM) (Millions $) 99
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) -6
 Dividend TTM ($) 4.95 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 425
   


  News about Medifast Inc Earnings

MEDIFAST INC: Profits Plummet and Competition Heats Up in 2023



Medifast Inc, a renowned health and wellness company known for its lifestyle solution OPTAVIA, recently reported its financial results for the fourth quarter and full year of 2023. While the company has embarked on a transformative business phase, expanding its reach in the health and wellness market, it is facing tough competition and experiencing significant declines in revenue and profitability.
Financial Performance:
In the fourth quarter of 2023, Medifast's net profit per share plummeted by a staggering -77.21%, dropping to $0.55 per share compared to $2.43 per share in the previous year. Earnings per share also fell by -73.86% to $2.12 per share. The company's revenue declined by -43....

Medifast Inc Overcomes Impressive Challenges, Celebrating Success in Q3 2023



Medifast Inc., the renowned health and wellness company, recently released its financial results for the third quarter ending September 30, 2023. The figures paint a mixed picture, as certain key metrics suffered significant declines, while others showed signs of improvement. In this article, we'll delve into the company's financial performance and assess its potential impact on Medifast's future.
Earnings and Income:
Medifast Inc.'s earnings per share (EPS) experienced a substantial drop of -35.17% in the July to September 30, 2023 interval, falling from $3.27 per share to $2.12 per share compared to the previous year. Additionally, net income decreased by -23.47% from $2.77 per share in t...

Medifast Inc Reports -19.01% Deterioration in EPS for the Most Recent Fiscal Period



Medifast Inc, a leading health and wellness company, recently released...

Conservative earnings per share Rise by 2.23 % at the Medifast Inc all along the fiscal span ending March 31 2023

Investing in the stock market can be a daunting task, especially in times of economic uncerta...


Date modified: 2024-02-21T11:56:58+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com